The University of California, Davis (UC Davis) received a $1,801,179 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 15, 2025, will support the university's research on the "Contribution of Bone Mass and Fracture to Bone Metastasis in Prostate Cancer" over a 3-year period through April 14, 2028.
As a prominent public research university, UC Davis frequently receives federal grants and contracts to conduct cutting-edge biomedical research, including studies on topics such as cardiac arrhythmias, fetal immune development, and novel cancer therapies. The CFDA 12.420 program funds a comprehensive range of military medical research initiatives, enabling academic institutions like UC Davis to investigate innovative solutions for improving health outcomes for service members, veterans, and the general public.
Generated 3/4/25, 8:34 AM